TATAA Biocenter Expands its microRNA profiling offering with Somagenics NGS library preparation kits
Göteborg, Sweden – TATAA Biocenter, Europe´s leading provider of genomic services, and SomaGenics, inventor of novel technology for the most efficient NGS library preparation of microRNA, announce collaboration in Europe, where TATAA will be offering exploratory microRNA profiling service and distribution of SomaGenics’s RealSeq® NGS products in Scandinavia, Czech and Slovak Republic.
microRNAs are most promising biomarkers found in tissues and body fluids. However, because of their short length they are challenging to measure with precision. SomaGenics’ new NGS library preparation technology requires only one adapter, which dramatically increases yield and reduces bias. “It is a perfect complement to the targeted microRNA profiling HTG Molecular platform we already have and our own targeted ultrasensitive and specific Two-Tailed PCR technology. With these three platforms we offer the most comprehensive microRNA profiling service in Europe,” says Mikael Kubista, CEO and founder of TATAA Biocenter.
Anne Scholz, Vice President Administration of SomaGenics stated, “SomaGenics is very excited to partner with TATAA Biocenter to extend TATAA’s current microRNA profiling service and product offerings. TATAA’s extensive network and popular training courses provide an excellent opportunity for us to expand customer access to our powerful RealSeq® technology. We are greatly looking forward to this partnership”
About TATAA Biocenter:
TATAA Biocenter is Europe’s leading provider of nucleic acid analysis services and world’s largest organizer of hands-on training in quantitative real-time PCR and Next Generation Sequencing. TATAA Biocenter offers a seamless workflow for high quality analyses of nucleic acids from experimental design, sample preparation, quality control, and data analysis, meeting the specific requirements for compliance with ISO17025 standard. TATAA is particularly known for its focus on quality, being member of the consortia SPIDIA (www.spidia.eu) and CANCERID (www.cancer-id.eu), developing guidelines and standard operating procedures for the diagnostic and pharmaceutical industries. TATAA also co-authored the MIQE guidelines teaching researchers how to report real-time PCR data. Founded in 2001, TATAA Biocenter has laboratories in Gothenburg, Sweden, and in Prague, Czech Republic. In 2013 TATAA Biocenter was presented the Frost & Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic Material. Visit us at: www.tataa.com
About Somagenics:
SomaGenics is a privately held biotech company specializing in developing innovative technologies that focus on RNA molecules as therapeutic agents and targets as well as biomarkers. The Company’s RNA analysis platforms include miR-ID®, a novel circularizationbased RT-qPCR method, miR-Direct® for microRNA analysis directly from biofluids, and the RealSeq® family of technologies for non-biased small RNA library construction for next generation sequencing. Visit us at www.somagenics.com

